Choroidal Thickness in Glaucoma Patients and Healthy Controls

• Conditions: Glaucoma Patients and Healthy Controls
• Interventions: Device: Spectralis® SD-OCT, Heidelberg Engineering GmbH, H

• Registration Number: NCT01293474
• Lead Sponsor: University of Zurich

Brief Summary

With the new software tool (EDI, enhanced depth imaging) of the Spectralis® spectral-domain optical coherence tomography (SD-OCT) it is possible to visualize and measure the choroidal thickness. In glaucoma a vascular component is known. Therefore a difference of choroidal thickness in glaucoma patients and healthy controls is proposed.

* Trial with medical device

Detailed Description

Not available

Study Timeline

• Study Start: 2011-02
• Study First Submitted: 2011-02-09
• Study First Submitted QC: 2011-02-09
• Study First Posted: 2011-02-10
• Status Verified: 2014-12
• Last Update Submitted: 2015-01-05
• Last Update Posted: 2015-01-06
• Primary Completion: 2015-12
• Study Completion: 2015-12

Recruitment & Eligibility

• Status: UNKNOWN
• Sex: All
• Target Recruitment: 200

Inclusion Criteria

Not provided

Exclusion Criteria

Not provided

Study & Design

• Study Type: OBSERVATIONAL
• Study Design: Not specified

Arm && Interventions

Group	Intervention	Description
glaucoma patients	Spectralis® SD-OCT, Heidelberg Engineering GmbH, H	patients with diagnosis of primary open angle glaucoma
control group	Spectralis® SD-OCT, Heidelberg Engineering GmbH, H	age matched healthy controls

Primary Outcome Measures

Name	Time	Method
COV	t0

Trial Locations

Locations (1)

University Hospital Zurich, Ophthalmic Clinic; 🇨🇭 Zurich, ZH, Switzerland